Tuberculosis Diagnosis and Vaccines Research
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines Against Tropical and Other Infectious Diseases".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 1325
Special Issue Editor
Special Issue Information
Dear Colleagues,
The Special Issue "Tuberculosis Diagnosis and Vaccines Research" aims to highlight the latest advancements in the detection and prevention of tuberculosis (TB), a significant global health threat. Despite ongoing efforts, TB remains one of the leading causes of death worldwide, exacerbated by the emergence of drug-resistant strains. This issue will focus on innovative diagnostic techniques, including molecular methods, imaging technologies, and biomarker discovery, which promise to enhance early detection and improve patient outcomes. Additionally, we invite contributions exploring novel vaccine candidates, immunological approaches, and the role of host-pathogen interactions in vaccine development. By fostering a multidisciplinary dialogue, this Special Issue seeks to bring together researchers, clinicians, and public health experts to share insights and propel the fight against TB. We encourage submissions that present cutting-edge bench research articles and Editorials, case studies, and review articles.
Dr. Shumaila Nida Javed Tunio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- developing new diagnostic methods
- new drugs
- new vaccines for tuberculosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
